Skip to main
EYES
EYES logo

EYES Earnings Dates & Reports

EYES Most Recent Earnings

Report DateJun 29, 2020
Period EndingQ1 2020
Est. EPS-$0.41
Actual EPS-$0.57
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

EYES Earnings per Share (EPS) History

Signup for full access
Browse free

EYES Latest Earnings

The value each EYES share was expected to gain vs. the value each share gained.

EYES reported its most recent earnings on Jun 29, 2020 for Q1 2020, posting earnings per share (EPS) of -$0.57. This exceeded analysts' expectations of -$0.41 by 39.02%, marking a Miss.

For comparison, Second Sight Medical Products reported EPS of $0 in the same quarter last year.

The company is expected to announce its next earnings report on 08/12/2022, with analysts projecting an EPS of $0.

EYES Earnings History

Earnings
Est. EPSActual EPSSurprise
Q2 2022Aug 12, 2022
-$0.08
Q1 2022May 16, 2022
-$0.06
Q4 2021Mar 29, 2022
-$0.02
Q3 2021Nov 12, 2021
-$0.06
Q2 2021Aug 13, 2021
-$0.08
View all

EYES Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Second Sight Medical Products’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
May 16, 2022
Mar 29, 2022
Nov 12, 2021
Aug 13, 2021

EYES Earnings FAQs

EYES last reported earnings on Jun 29, 2020 for Q1 2020, posting an EPS of -$0.57, which Miss the estimate of -$0.41 by 39.02%.

For Q1 2020, EYES reported an EPS of -$0.57, missing analysts' estimate of -$0.41 by 39.02%.

For Q1 2020, EYES Miss expectations with an actual EPS of -$0.57 vs. an estimated EPS of -$0.41.

Following the last earnings report on Jun 29, 2020, EYES's stock price moved — from — to —.

The next EYES earnings call is scheduled for Aug. 12, 2022, where executives will discuss financial results and outlook.

Second Sight Medical Products (EYES)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.